Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125607003 | 12560700 | 3 | F | 20160708 | 20160915 | 20160715 | 20160922 | EXP | US-ROCHE-1793513 | ROCHE | 69.68 | YR | M | Y | 104.30000 | KG | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125607003 | 12560700 | 1 | PS | Atezolizumab | ATEZOLIZUMAB | 1 | Intravenous (not otherwise specified) | THE DATE OF LAST DOSE PRIOR TO AE ONSET WAS ON 30/JUN/2016 | 761034 | 1200 | MG | ||||||||
| 125607003 | 12560700 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | THE DATE OF LAST DOSE PRIOR TO AE ONSET WAS ON 30/JUN/2016 | 0 | 900 | MG | ||||||||
| 125607003 | 12560700 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | THE DATE OF LAST DOSE PRIOR TO AE ONSET WAS ON 30/JUN/2016 | 0 | 446 | MG | ||||||||
| 125607003 | 12560700 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | 5 | MG | |||||||||
| 125607003 | 12560700 | 5 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | 0 | .125 | MG | |||||||||
| 125607003 | 12560700 | 6 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | 50 | MG | |||||||||
| 125607003 | 12560700 | 7 | C | CASPOFUNGIN | CASPOFUNGIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125607003 | 12560700 | 1 | Non-small cell lung cancer stage IV |
| 125607003 | 12560700 | 2 | Non-small cell lung cancer stage IV |
| 125607003 | 12560700 | 3 | Non-small cell lung cancer stage IV |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125607003 | 12560700 | DE |
| 125607003 | 12560700 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125607003 | 12560700 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125607003 | 12560700 | 1 | 20160630 | 0 | ||
| 125607003 | 12560700 | 2 | 20160630 | 0 | ||
| 125607003 | 12560700 | 3 | 20160630 | 0 | ||
| 125607003 | 12560700 | 7 | 20160716 | 0 |